Overview
Chart
Returns
Asset Allocation
Fund Info
Risk & Return Ratio
Other Info
Fund Overview
  • Rating
    4
  • Minimum Investment
    ₹5000
  • NAV (Net Asset Value)
    ₹N/A
  • AUM (Fund size)
    ₹6862 Cr
  • Created on
    5 July 2018
Fund Ranking
#7
/ 19 in Sectoral-Pharma
Risk Level

Very High

Loading...
Returns
Trailing Return
Rolling Return
  • 6 Month
    7.0%
  • 1 Year
    2.1%
  • 3 Year (CAGR)
    19.4%
  • All Time (CAGR)
    18.7%
Category Return
  • 6 Month
    10.9%
  • 1 Year
    8.5%
  • 3 Year (CAGR)
    18.8%
  • All Time (CAGR)
    16.8%
Asset Allocation
  • Equity
    98.9%
  • Other
    1.1%
Top 5 Holdings
Top 5 Sectors
  • Aarti Drugs
    1.17%
  • Apollo Hospitals Enterprise
    2.30%
  • Astrazeneca Pharma India
    1.85%
  • Cipla
    5.79%
  • Dr. Reddy's Laboratories
    9.73%
Fund Information
  • Expense Ratio
    2.07%
  • Exit Load
    Exit load of 1% if redeemed within 15 days.
  • Lock-In Period
    No Lock-In

Managed By

Dharmesh Kakkad
May 2020 - Present
Sharmila D'Silva
July 2022 - Present
Risk & Return Ratio
  • Sharpe Ratio
    0.87
  • Standard Deviation
    16.40
  • Alpha
    -0.28
  • Beta
    0.96
Disclaimer: Mutual fund investments are subject to market risks, read all scheme related documents carefully.